A detailed history of Cibc Asset Management Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cibc Asset Management Inc holds 399,033 shares of MRK stock, worth $39.2 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
399,033
Previous 405,167 1.51%
Holding current value
$39.2 Million
Previous $50.2 Million 9.66%
% of portfolio
0.16%
Previous 0.19%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$111.15 - $128.97 $681,794 - $791,101
-6,134 Reduced 1.51%
399,033 $45.3 Million
Q2 2024

Aug 01, 2024

SELL
$123.8 - $132.96 $11 Million - $11.8 Million
-88,465 Reduced 17.92%
405,167 $50.2 Million
Q1 2024

May 09, 2024

BUY
$113.24 - $131.95 $1.04 Million - $1.21 Million
9,173 Added 1.89%
493,632 $65.1 Million
Q4 2023

Feb 13, 2024

SELL
$100.18 - $109.02 $1.87 Million - $2.03 Million
-18,651 Reduced 3.71%
484,459 $52.8 Million
Q3 2023

Oct 30, 2023

SELL
$102.95 - $114.33 $881,149 - $978,550
-8,559 Reduced 1.67%
503,110 $51.8 Million
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $1.35 Million - $1.47 Million
-12,431 Reduced 2.37%
511,669 $59 Million
Q1 2023

May 12, 2023

SELL
$102.94 - $114.86 $881,989 - $984,120
-8,568 Reduced 1.61%
524,100 $55.8 Million
Q4 2022

Feb 13, 2023

SELL
$87.44 - $112.11 $9.53 Million - $12.2 Million
-109,023 Reduced 16.99%
532,668 $59.1 Million
Q3 2022

Nov 03, 2022

BUY
$84.53 - $94.96 $9.77 Million - $11 Million
115,524 Added 21.96%
641,691 $55.3 Million
Q2 2022

Aug 09, 2022

SELL
$83.49 - $94.64 $1.46 Million - $1.66 Million
-17,511 Reduced 3.22%
526,167 $48 Million
Q1 2022

May 06, 2022

BUY
$73.51 - $82.4 $12.7 Million - $14.2 Million
172,587 Added 46.51%
543,678 $44.6 Million
Q4 2021

Feb 08, 2022

SELL
$72.28 - $90.54 $10.1 Million - $12.6 Million
-139,625 Reduced 27.34%
371,091 $28.4 Million
Q3 2021

Nov 09, 2021

SELL
$71.68 - $78.83 $1.66 Million - $1.83 Million
-23,183 Reduced 4.34%
510,716 $38.4 Million
Q2 2021

Aug 16, 2021

BUY
$70.31 - $77.77 $1.06 Million - $1.17 Million
15,094 Added 2.91%
533,899 $41.5 Million
Q1 2021

May 14, 2021

BUY
$68.86 - $81.11 $1.27 Million - $1.5 Million
18,484 Added 3.69%
518,805 $40 Million
Q4 2020

Feb 03, 2021

BUY
$71.77 - $79.65 $956,622 - $1.06 Million
13,329 Added 2.74%
500,321 $40.9 Million
Q3 2020

Nov 05, 2020

BUY
$73.18 - $82.95 $271,131 - $307,329
3,705 Added 0.77%
486,992 $40.4 Million
Q2 2020

Jul 28, 2020

BUY
$70.42 - $80.13 $7.21 Million - $8.2 Million
102,335 Added 26.86%
483,287 $37.4 Million
Q1 2020

Apr 30, 2020

BUY
$63.36 - $87.82 $8.59 Million - $11.9 Million
135,532 Added 55.22%
380,952 $29.3 Million
Q4 2019

Feb 14, 2020

SELL
$77.58 - $87.54 $1.04 Million - $1.17 Million
-13,355 Reduced 5.16%
245,420 $22.3 Million
Q3 2019

Oct 30, 2019

SELL
$76.08 - $82.93 $106,816 - $116,433
-1,404 Reduced 0.54%
258,775 $21.8 Million
Q2 2019

Aug 05, 2019

BUY
$69.84 - $81.59 $604,325 - $705,998
8,653 Added 3.44%
260,179 $21.8 Million
Q1 2019

May 06, 2019

BUY
$69.58 - $79.36 $575,426 - $656,307
8,270 Added 3.4%
251,526 $20.9 Million
Q4 2018

Feb 12, 2019

SELL
$65.24 - $75.71 $6.49 Million - $7.53 Million
-99,506 Reduced 29.03%
243,256 $18.6 Million
Q3 2018

Nov 02, 2018

SELL
$57.69 - $67.84 $23.4 Million - $27.5 Million
-405,569 Reduced 54.2%
342,762 $24.3 Million
Q2 2018

Aug 09, 2018

SELL
$50.83 - $59.72 $3.23 Million - $3.79 Million
-63,486 Reduced 7.82%
748,331 $45.4 Million
Q1 2018

Apr 30, 2018

SELL
$50.96 - $59.23 $5.59 Million - $6.5 Million
-109,700 Reduced 11.9%
811,817 $44.2 Million
Q4 2017

Feb 02, 2018

BUY
$51.62 - $61.64 $30.1 Million - $36 Million
583,511 Added 172.63%
921,517 $51.9 Million
Q3 2017

Nov 06, 2017

BUY
$58.67 - $63.13 $19.8 Million - $21.3 Million
338,006
338,006 $21.6 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $249B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Cibc Asset Management Inc Portfolio

Follow Cibc Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.